CYP2D6 in the brain: genotype effects on resting brain perfusion

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Molecular Psychiatry

• Publication date

  2011-03-01

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1038/mp.2010.42PMID 20368706
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Baseline brain perfusion and the serotonin transporter promoter polymorphism.

  2010cited by this paper
• Components of variance in brain perfusion and the design of studies of individual differences: The baseline study

  2009cited by this paper
• Association between the CYP2D6*4 polymorphism and depression or anxiety in the elderly.

  2009cited by this paper
• Relation between CYP2D6 genotype, personality, neurocognition and overall psychopathology in healthy volunteers.

  2009cited by this paper
• CYP2D6: a key enzyme in morphine synthesis in animals.

  2008cited by this paper
• Induction of the drug metabolizing enzyme CYP2D in monkey brain by chronic nicotine treatment.

  2008cited by this paper
• Habitual emotion regulation strategies and baseline brain perfusion

  2008cited by this paper
• Chronic nicotine treatment induces rat CYP2D in the brain but not in the liver: an investigation of induction and time course.

  2008cited by this paper
• The Endocannabinoid Anandamide Is a Substrate for the Human Polymorphic Cytochrome P450 2D6

  2008cited by this paper
• The CYP2D6 Activity Score: Translating Genotype Information into a Qualitative Measure of Phenotype

  2008cited by this paper
• Relation between CYP2D6 phenotype and genotype and personality in healthy volunteers.

  2008cited by this paper
• Misunderstandings between experimentalists and observationalists about causal inference

  2008cited by this paper
• Genetic variation in serotonin transporter alters resting brain function in healthy individuals.

  2007cited by this paper
• No association between CYP2D6 polymorphisms and personality trait in Japanese.

  2007cited by this paper
• Association between cytochrome P450 (CYP) 2C19 polymorphisms and harm avoidance in Japanese

  2007cited by this paper
• CYP2D6 polymorphism: implications for antipsychotic drug response, schizophrenia and personality traits.

  2007cited by this paper
• Matching as Nonparametric Preprocessing for Reducing Model Dependence in Parametric Causal Inference

  2007cited by this paper
• Neural correlates of epigenesis

  2006cited by this paper
• Association of CYP2D6 genotypes and personality traits in healthy individuals.

  2006cited by this paper
• AmpliChip CYP450 GeneChip®: A New Gene Chip That Allows Rapid and Accurate CYP2D6 Genotyping

  2006cited by this paper
• Neural correlates of individual differences in pain‐related fear and anxiety

  2006cited by this paper
• Intrinsic brain activity sets the stage for expression of motivated behavior

  2005cited by this paper
• Amplitude-modulated continuous arterial spin-labeling 3.0-T perfusion MR imaging with a single coil: feasibility study.

  2005cited by this paper
• Association between cytochrome P450 2D6 genotype and harm avoidance

  2004cited by this paper
• Molecular diversity at the CYP2D6 locus in the Mediterranean region

  2004cited by this paper
• Full Matching in an Observational Study of Coaching for the SAT

  2004cited by this paper
• Relationship between Type A and B personality and debrisoquine hydroxylation capacity.

  2004cited by this paper
• Regeneration of serotonin from 5-methoxytryptamine by polymorphic human CYP2D6.

  2003cited by this paper
• Positron emission tomography imaging in depression: a neural systems perspective.

  2003cited by this paper
• Observational Studies

  2003cited by this paper
• Linearized Reference Tissue Parametric Imaging Methods: Application to [11C]DASB Positron Emission Tomography Studies of the Serotonin Transporter in Human Brain

  2003cited by this paper
• Arterial transit time imaging with flow encoding arterial spin tagging (FEAST)

  2003cited by this paper
• Controlling the familywise error rate in functional neuroimaging: a comparative review

  2003cited by this paper
• Cytochrome P450 2D6 polymorphism and character traits

  2003cited by this paper
• CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants.

  2002cited by this paper
• Regional and cellular expression of CYP2D6 in human brain: higher levels in alcoholics

  2002cited by this paper
• CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants.

  2002cited by this paper
• Cellular localization and regional distribution of CYP2D6 mRNA and protein expression in human brain.

  2001cited by this paper
• The amygdala: vigilance and emotion

  2001cited by this paper
• Inaugural Article: A default mode of brain function

  2001cited by this paper
• Functional neuroimaging of normal human sleep by positron emission tomography

  2000cited by this paper
• Neuroimaging studies of mood disorders.

  2000cited by this paper
• Neural correlates of attention and arousal: insights from electrophysiology, functional neuroimaging and psychopharmacology.

  1998cited by this paper
• The inferential impact of global signal covariates in functional neuroimaging analyses.

  1998cited by this paper
• Dopamine formation from tyramine by CYP2D6.

  1998cited by this paper
• Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences.

  1997cited by this paper
• Common Blood Flow Changes across Visual Tasks: II. Decreases in Cerebral Cortex

  1997cited by this paper
• Time-Related Changes in Neural Systems Underlying Attention and Arousal During the Performance of an Auditory Vigilance Task

  1997cited by this paper
• Nonparametric Analysis of Statistic Images from Functional Mapping Experiments

  1996cited by this paper
• Activation by Attention of the Human Reticular Formation and Thalamic Intralaminar Nuclei

  1996cited by this paper
• The Cognitive Neurosciences

  1996cited by this paper
• Remembering the past: two facets of episodic memory explored with positron emission tomography.

  1995cited by this paper
• Attention in cognitive neuroscience: An overview.

  1995cited by this paper
• Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord

  1995cited by this paper
• Neurobiology of cingulate cortex and limbic thalamus

  1994cited by this paper
• Statistical parametric maps in functional imaging: A general linear approach

  1994cited by this paper
• Making Love Again

  1994cited by this paper
• Relationship between personality and debrisoquine hydroxylation capacity

  1993cited by this paper
• Neurotransmitter actions in the thalamus and cerebral cortex and their role in neuromodulation of thalamocortical activity.

  1992cited by this paper
• Cortical and subcortical localization of response to pain in man using positron emission tomography

  1991cited by this paper
• The Relationship between Global and Local Changes in PET Scans

  1990cited by this paper
• Characterization of a human liver cytochrome P-450 involved in the oxidation of debrisoquine and other drugs by using antibodies raised to the analogous rat enzyme.

  1984cited by this paper
• Précis of The neuropsychology of anxiety: An enquiry into the functions of the septo-hippocampal system

  1982cited by this paper
• The neuropsychology of anxiety

  1982cited by this paper
• Matched Sampling for Causal Effects: Matching to Remove Bias in Observational Studies

  1973cited by this paper

• Single molecule long-read real-time amplicon-based sequencing of CYP2D6: a proof-of-concept with hybrid haplotypes

  2026cites this paper
• Translating Molecular Psychiatry: From Biomarkers to Personalized Therapies—A Narrative Review

  2025cites this paper
• Brain Cytochrome P450: Navigating Neurological Health and Metabolic Regulation

  2025cites this paper
• Pharmaco-toxicological effects of the novel tryptamine hallucinogen 5-MeO-MiPT on motor, sensorimotor, physiological, and cardiorespiratory parameters in mice—from a human poisoning case to the preclinical evidence

  2024cites this paper
• Human CYP2D6 varies across the estrous cycle in brains of transgenic mice altering drug response.

  2024cites this paper
• Novel Independent Trans- and Cis-Genetic Variants Associated with CYP2D6 Expression and Activity in Human Livers

  2023cites this paper
• Haplotype phasing of CYP2D6: an allelic ratio method using Agena MassARRAY data

  2023cites this paper
• CYP450 2D6 and 2C19 genotypes in ADHD: not related with treatment resistance but with over-representation of 2C19 ultra-metabolizers

  2022cites this paper
• Association study identifies genetic determinants and non-genetic factors on steady-state plasma and therapeutic outcome of galantamine in mixed dementia

  2022cites this paper
• Pharmacogenomics in Psychiatry Practice: The Value and the Challenges

  2022cites this paper
• Influence of cytochrome P450 2D6 polymorphism on hippocampal white matter and treatment response in schizophrenia

  2021cites this paper
• CYP2D6 in the Brain: Potential Impact on Adverse Drug Reactions in the Central Nervous System—Results From the ADRED Study

  2021cites this paper
• Pharmacogenomics in the era of next generation sequencing – from byte to bedside

  2021cites this paper
• Cytochrome P450 expression and regulation in the brain

  2020cites this paper
• Human CYP2D6 in the Brain Is Protective Against Harmine-Induced Neurotoxicity: Evidence from Humanized CYP2D6 Transgenic Mice

  2020cites this paper
• Human CYP2D6 Is Functional in Brain In Vivo: Evidence from Humanized CYP2D6 Transgenic Mice

  2020cites this paper
• PGPM_A_211259 209..224

  2019cites this paper
• Effects of genetic variability of CYP2D6 on neural substrates of sustained attention during on-task activity

  2019cites this paper
• Influence of CYP2D6, CYP3A5, ABCB1, APOE polymorphisms and nongenetic factors on donepezil treatment in patients with Alzheimer’s disease and vascular dementia

  2019cites this paper
• Accelerated 3D‐GRASE imaging improves quantitative multiple post labeling delay arterial spin labeling

  2018cites this paper
• Imaging in Pharmacogenetics.

  2018cites this paper
• The activity of brain and liver cytochrome P450 2D (CYP2D) is differently affected by antidepressants in the chronic mild stress (CMS) model of depression in the rat

  2018cites this paper
• Transcriptional Regulation of CYP2D6 Expression

  2017cites this paper
• CYP‐mediated drug metabolism in the brain impacts drug response

  2017cites this paper
• Predicting CYP2D6 phenotype from resting brain perfusion images by gradient boosting.

  2017cites this paper
• High Frequency of CYP2D6 Ultrarapid Metabolizer Genotype in the Finnish Population

  2016cites this paper
• Running title : CYP 2 D 6 transcriptional regulation

  2016cites this paper
• Emerging roles for brain drug-metabolizing cytochrome P450 enzymes in neuropsychiatric conditions and responses to drugs

  2016influential citation
• Pathophysiological implications of neurovascular P450 in brain disorders.

  2016cites this paper
• The relationship between methylation and genes associated with opioid response in humans

  2016cites this paper
• The expression and function of P 450 enzymes at the neurovascular unit have a key role in drug resistance and brain cell viability . Pathophysiological implications of neurovascular P 450 in brain disorders

  2016cites this paper
• Hepatocyte nuclear factor (HNF) 4α transactivation of cytochrome P450 (Cyp) 2d40 promoter is enhanced during pregnancy in mice.

  2015cites this paper
• Polymorphism in CYP2D6 and CYP2C19, members of the cytochrome P450 mixed‐function oxidase system, in the metabolism of psychotropic drugs

  2015cites this paper
• “Target-Site” Drug Metabolism and Transport

  2015cites this paper
• Occurrence, distribution and potential actions of CYP2D6 in the brain

  2014cites this paper
• CYP2D6 variation, behaviour and psychopathology: implications for pharmacogenomics-guided clinical trials.

  2014cites this paper
• Krüppel-Like Factor 9 Promotes Hepatic Cytochrome P 450 2 D 6 Expression during Pregnancy in CYP 2 D 6-Humanized Mice s

  2014cites this paper
• Use of magnetic resonance imaging in pharmacogenomics.

  2014cites this paper
• CYP2D6 and pharmacogenomics: where does future research need to focus? Part 2: clinical aspects.

  2014cites this paper
• Krüppel-Like Factor 9 Promotes Hepatic Cytochrome P450 2D6 Expression during Pregnancy in CYP2D6-Humanized Mice

  2014cites this paper
• Ethanol self‐administration and nicotine treatment increase brain levels of CYP2D in African green monkeys

  2014cites this paper
• Pharmacogenomics of Cytochrome P450 Dependent Metabolism of Endogenous Compounds: Implications for Behavior, Psychopathology and Treatment

  2014cites this paper
• "…the primary challenge for future research is to step back and critically assess the knowledge deficits, and design appropriate studies to generate convincing evidence to justify a change in practice…"

  2014cites this paper
• Krüppel-like Factor 9 (KLF9) Promotes hepatic Cytochrome P450 (CYP) 2D6 Expression during Pregnancy in CYP2D6-humanized Mice Role of KLF9 in CYP2D6 induction during pregnancy

  2014cites this paper
• Cytochrome P450-mediated drug metabolism in the brain.

  2013cites this paper
• Role of brain cytochrome P450 (CYP2D) in the metabolism of monoaminergic neurotransmitters

  2013cites this paper
• Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function

  2013cites this paper
• Heinz Lehmann Award paper Cytochrome P 450 – mediated drug metabolism in the brain

  2013cites this paper
• Influence of CYP2D6 and CYP2C19 gene variants on antidepressant response in obsessive-compulsive disorder

  2013cites this paper
• Recent examples on the clinical relevance of the CYP2D6 polymorphism and endogenous functionality of CYP2D6

  2013cites this paper
• The Expression and Regulation of CYP2D in a Monkey Model of Ethanol and Nicotine Exposure

  2013cites this paper
• CYP2C19 and brain development : implications for susceptibility to anxiety in a transgenic mouse model

  2013cites this paper
• Melatonin and synthetic melatonergic agonists: actions and metabolism in the central nervous system.

  2012cites this paper
• An Investigation of CYP2B in Rat Brain: Regulation and Role in Drug and Toxin Response

  2012cites this paper
• Inhibition of Brain CYP2D Lowers Codeine-induced Analgesia in Rats

  2012cites this paper
• Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects

  2012cites this paper
• Pharmacogenetics of Psychoactive Drugs

  2012cites this paper
• Pharmacogenetics of obsessive-compulsive disorders.

  2012cites this paper
• Metabolic Activity in the Insular Cortex and Hypothalamus Predicts Hot Flashes: An FDG-PET Study

  2012cites this paper
• Genetic variation in CYP2D6 impacts neural activation during cognitive tasks in humans

  2012influential citation
• The AmpliChip® CYP450 Test and Response to Treatment in Schizophrenia and Obsessive Compulsive Disorder: A Pilot Study and Focus on Cases with Abnormal CYP2D6 Drug Metabolism

  2012cites this paper
• CYP2D6 in the Brain: Impact on Suicidality

  2011cites this paper
• Cytochromes P450 in the brain: Emerging evidence for biological significance

  2011cites this paper
• Drug Metabolism within the Brain Changes Drug Response: Selective Manipulation of Brain CYP2B Alters Propofol Effects

  2011cites this paper
• Cytochrome P450 enzymes in the brain: emerging evidence of biological significance.

  2011cites this paper
• Effects of large-scale nonstationarity on parametric maps. A study of rest perfusion CASL data

  2011cites this paper
• CYP 2D6 PM Status and Antidepressant Response to Nortriptyline and Venlafaxine: Is It More Than Just Drug Metabolism?

  2011cites this paper
• CYP2A6 and CYP2B6 Genetic Variation, and Tobacco Use Behaviours and Biomarkers in Alaska Natives

  2011influential citation
• Cytochrome P450 mediates dopamine formation in the brain in vivo

  2011cites this paper
• Imaging genetics: implications for research on variable antidepressant drug response

  2010cites this paper
• Xenobiotic metabolizing and transporter genes: gene-gene interactions in schizophrenia and related disorders.

  2010cites this paper